Committed to Becoming the Most Trusted International Pharmaceutical Company
Innovation and quality guide everything we do at Haisco. Our core products protect health and bring the reliability of Chinese-developed medicines to patients worldwide.
Haisco Pharmaceutical Group focuses on five major therapeutic areas: Anesthesia and Analgesia, Chronic Metabolic Diseases, Respiratory Disease, Autoimmune Disease, and Oncology. The Group markets more than 46 drugs, including four Class 1 innovative drugs covered by China's national medical insurance program.
Anesthesia and AnalgesiaEndocrine SystemEnteral and Parenteral NutritionNeurological and Psychiatric SystemCardiovascular SystemOncologyDigestive and Hepatic DiseasesAndrologyOthers
COPYRIGHT 2026 @ HAISCO Pharmaceutical Group Co., Ltd.
Zang ICP Registration No. 20000012-1 Shu ICP Registration No. 16033962-2Shu ICP No. 16033962-3 The Tibetan public network security registration number is 54222102000053.(Tibetan)-Non-operational-2019-0003